Cost-effectiveness of expanded newborn screening in Texas

Value in Health

Volumn 15, Issue 5, 2012, Pages 613-621

  Tiwana, Simrandeep K ^a,b   Rascati, Karen L ^b   Park, Haesuk ^b  

^a ALBERTA HEALTH SERVICES   (Canada)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

children; cost effectiveness analysis; health economics methods; model; quality adjusted life years

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE QUALITY; LIFESPAN; NEWBORN SCREENING; PRIORITY JOURNAL; PROBABILITY; QUALITY OF LIFE; SENSITIVITY ANALYSIS; UNITED STATES;

COST-BENEFIT ANALYSIS; FEMALE; HUMANS; INFANT, NEWBORN; MALE; MARKOV CHAINS; METABOLISM, INBORN ERRORS; MODELS, ECONOMIC; NEONATAL SCREENING; QUALITY-ADJUSTED LIFE YEARS; TEXAS;

EID: 84864608901     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2012.02.007     Document Type: Article

References (32)

1. B.L. Therrell Jr. U.S. newborn screening policy dilemmas for the twenty-first century Mol Genet Metab 74 2001 64 74
2. R. Guthrie, A. Susi A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants Pediatrics 32 1963 338 343
3. E.J. Schoen, J.C. Baker Cost-benefit analysis of universal tandem mass spectrometry for newborn screening Pediatrics 110 2002 781 786
4. R.P. Insinga, R.H. Laessig, G.L. Hoffman Newborn screening with tandem mass spectrometry: examining its cost-effectiveness in the Wisconsin Newborn Screening Panel J Pediatr 141 2002 524 531
5. L.N. Venditti, C.P. Venditti, G.T. Berry Newborn screening by tandem mass spectrometry for medium-chain acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis Pediatrics 112 2003 1005 1015
6. K. Tran, S. Banerjee, H. Li Clinical efficacy and cost-effectiveness of newborn screening for medium chain acyl-CoA dehydrogenase deficiency using tandem mass spectrometry Clin Biochem 40 2007 235 241
7. A.E. Carroll, S.M. Downs Comprehensive cost-utility analysis of newborn screening strategies Pediatrics 117 Suppl. 2006 S287 S295
8. L. Feuchtbaum, G. Cunningham Economic evaluation of tandem mass spectrometry screening in California Pediatrics 117 Suppl. 2006 S280 S286
9. L.E. Cipriano, C.A. Rupar, G.S. Zaric The cost-effectiveness of expanding newborn screening for up to 21 inherited metabolic disorders using tandem mass spectrometry: results from a decision-analytic model Value Health 10 2007 83 97
10. M.S. Watson, M.Y. Mann, M.A. Lloyd-Puryear Newborn screening: toward a uniform panel and system Executive summary Gen Med 8 Suppl. 2006 1S 11
11. M. Drummond-Borg S. Tiwana, 2007 Austin, TX
12. S.H. Mudd, F. Skovby, H.L. Levy The natural history of homocystinuria due to cystathionine beta-synthase deficiency Am J Hum Genet 37 1985 1 31
13. (8th ed.) C.R. Scriver, A.L. Beaudet, D. Valle The Metabolic and Molecular Bases of Inherited Disease 2001 McGraw-Hill New York
14. D.H. Morton, K.A. Strauss, D.L. Robinson Diagnosis and treatment of maple syrup disease: a study of 36 patients Pediatrics 109 2002 999 1008
15. L.A. Prosser, C.Y. Kong, D. Rusinak, S.L. Waisbren Projected costs, risks, and benefits of expanded newborn screening for MCADD Pediatrics 125 2010 e286 e294
16. B. Wilcken, J. Hammond, M. Silink Morbidity and mortality in medium chain acyl coenzyme A dehydrogenase deficiency Arch Dis Child 70 5 1994 410 412
17. M. Kyllerman, O.H. Skjeldal, M. Lundberg Dystonia and dyskinesia in glutaric aciduria type I: clinical heterogeneity and therapeutic considerations Mov Disord 9 1994 22 30
18. K.A. Strauss, E.G. Puffenberger, D.L. Robinson Type I glutaric aciduria, part 1: natural history of 77 patients Am J Med Genet C Semin Med Genet 121C 2003 38 52
19. C. Dionisi-Vici, F. Deodato, W. Röschinger 'Classical' organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: long-term outcome and effects of expanded newborn screening using tandem mass spectrometry J Inherit Metab Dis 29 2006 383 389
20. D.H. Smith, C.M. Guillon, G. Nicholas Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population J Am Soc Nephrol 15 2004 1300 1306
21. Grosse SD, Shimabukuro TT. Direct medical costs of autism in a privately insured population 2002. Presented at: Academy Health Meeting, Boston, MA, 2002.
22. M. Haas, M. Chaplin, P. Joy Healthcare use and costs of medium-chain acyl-CoA dehydrogenase deficiency in Australia: screening versus no screening J Pediatr 151 2007 121-6.126 e1
23. H.W. Hsu, T.H. Zytokovicz, A.M. Comeau Spectrum of medium-chain acyl-CoA dehydrogenase deficiency detected by newborn screening Pediatrics 121 2008 e1108 e1114
24. B.G. Busbee, M.M. Brown, C.G. Brown, S. Sharma Incremental cost-effectiveness of initial cataract surgery Ophthalmology 109 2002 606 612 discussion 612-3
25. A. Honeycutt, S. Grosse, L. Dunlap Economic costs of mental retardation, cerebral palsy, hearing loss, and vision impairment B.M. Altman, S.N. Barnartt, G.E. Hendershot, S.A. Larson, Using Survey Data to Study Disability: Results from the National Health Survey on Disability (Research in Social Science and Disability, Vol. 3) 2003 Emerald Group Publishing Limited Bingley, UK
26. J.Y. Yeh Cost-Effectiveness Analyses of Anti-Resorptive Agents for Management of Glucocorticoid-Induced Osteoporosis and Fractures: Empirical Estimates from the 1996-2004 MEPS Data and Longitudinal Projection from Markov Modeling [Ph.D. thesis] 2007 The University of Texas at Austin Austin, TX
27. G.A. de Wit, P.J. Ramsteijn, F.T. de Charro Economic evaluation of end stage renal disease treatment Health Policy 44 1998 215 232
28. M.R. Arguedas, V.K. Chen, M.A. Eloubeidi Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis Am J Gastroenterol 98 2003 679 690
29. A.E. Carroll, S.M. Downs Improving decision analyses: parent preferences (utility values) for pediatric health outcomes J Pediatr 155 2009 21 25 25e1-5
30. V.R. Sutton Standard practice for MCADD S.K. Tiwana, 2010
31. C.R. Roe, J. Ding Mitochondrial fatty acid oxidation disorders C.R. Scriver, A.L. Beaudet, D. Valle, The Metabolic and Molecular Bases of Inherited Disease 2001 McGraw-Hill New York 2297 2326
32. B. Wilcken, M. Haas, P. Joy Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study Lancet 369 2007 37 42